Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
J.F. Kerr, A.H. Wyllie, A.R. Currie.
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.
Br J Cancer, 26 (1972), pp. 239-257
[2.]
G. Evan, T. Littlewood.
A matter of life and cell death.
Science, 281 (1998), pp. 1317-1322
[3.]
M. Vaquero.
Apoptosis: ser o no ser, ésa es la cuestion.
Med Clin (Barc), 114 (2000), pp. 144-156
[4.]
B.D. Steward.
Mechanisms of apoptosis: integration of genetic, biochemical and cellular indicators.
J Natl Cancer Inst, 86 (1994), pp. 1286-1296
[5.]
M.L. Joris.
Apoptosis, oncosis and necrosis. An overview of cell death.
Am J Pathol, 146 (1995), pp. 3-5
[8.]
B.F. Trump, I.K. Berezesky, S.H. Chang, P.C. Phelps.
The pathway of cell death; Oncosis, Apoptosis and Necrosis.
Toxicol Pathol, 25 (1997), pp. 82-88
[9.]
A. Haunstetter, S. Izumo.
Apoptosis: basic mechanisms and implications in cardiovascular disease.
Cir Res, 82 (1998), pp. 1111-1129
[10.]
M.M. Kockx, G.R.Y. De Meyer, J. Muhring.
Apoptosis and related proteins in different stages of human atherosclerotic plaques.
Circulation, 97 (1998), pp. 2307-2315
[12.]
D. de Blois, S.N. Orlov, P. Hamet.
Apoptosis in cardiovascular remodeling- effect of medication.
Cardiovasc Drugs Ther, 15 (2001), pp. 539-545
[13.]
G.Z. Feuerstein, P.R. Young.
Apoptosis in cardiac diseases: stress and mitogen-activated signaling pathways.
Cardiovasc Res, 45 (2000), pp. 560-569
[14.]
Y. Gavrieli, Y. Sherman, S.A. Ben-Sasson.
Identification of programmed cell-death in situ via specific labeling of nuclear DNA fragmentation.
J Cell Biol, 119 (1992), pp. 493-501
[15.]
F.G. Blankenberg, H.W. Strauss.
Noninvasive strategies to image cardiovascular apoptosis.
Cardiol Clin, 19 (2001), pp. 165-172
[16.]
P.J.M. Best, D. Hasadi, E. Samgiorgi.
Apoptosis: basic concepts and implications in coronary artery disease.
Arterioscler Thromb Vasc Biol, 19 (1999), pp. 14-22
[17.]
G.D. Dispersyn, L. Mesotten, B. Meuris, A. Maes, L. Mortelmans, W. Flameng, et al.
Dissotiation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones.
Eur Hear J, 23 (2002), pp. 849-857
[18.]
E. Olje, O.P. Clausen, A. Yndestad, H.K. Grogaard, H. Attramadal.
Endothelin receptor antagonism atenuates cardiomyocyte apoptosis after induction of ischemia in rats.
Scand Cardiovasc J, 36 (2002), pp. 108-116
[19.]
Q. Li, B. Li, X. Wang.
Overexpression of insulin-like growth factor 1 in mice protects from myocyte death after infarction, attenuating ventricular dilatation, wall stress, and cardiac hyperthophy.
J Clin Invest, 100:0 (1997), pp. 1991-1999
[20.]
W.S. Colucci.
Apoptosis in the heart.
N Engl J Med, 335 (1996), pp. 1224-1226
[21.]
R.M. Gurevich, K.M. Regula, L.A. Kirshenbaum.
Serpin protein CrmA supresses hypoxia-mediated apoptosis of ventricular myocytes.
Circulation, 103 (2001), pp. 1984-1991
[22.]
H. Sakuma, M. Yamamoto, M. Okumura, T. Kojima, T. Maruyama, K. Yasuda.
High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1/A1.
Am J Physiol Cell Physiol, 263 (2002), pp. C422-c428
[23.]
J.M. Isner, M. Kearney, S. Bortman, J. Passeri.
Apoptosis in human atherosclerosis and reestenosis.
Circulation, 91 (1995), pp. 2703-2711
[24.]
G. Bauiedel, G. Schluckebier, R. Hutter.
Apoptosis in reestenosis versus stable angina. Implication for the pathogenesis of reestenosis.
Atherioscler Thromb Vasc Biol, 18 (1998), pp. 1132-1139
[25.]
M. Sata, H. Perlam, D.A. Muruve.
Fas ligand gene transfer to the vessel wall inhibits neointima formation and overrides the adenovirusmediated T cell response.
Proc Natl Acad Sci USA, 95 (1998), pp. 1213-1217
[27.]
H. Perlman, L. Maillard, K. Krasinski, K. Walsh.
Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury.
Circulation, 95 (1997), pp. 981-987
[28.]
C. Dong, J.E. Wilson, J.L. Winters.
Human transplant coronary artery disease: pathological evidence for Fas-mediated apoptotic cytotoxicity in allograft arteriopathy.
Lab Invest, 74 (1996), pp. 921-931
[29.]
T. Stefanec.
Endothelial apoptosis: could it have a role in the pathogenesis and treatment of disease?.
Chest, 117 (2000), pp. 841-854
[30.]
P. Anversa, B. Nadal-Ginard.
Myocyte renewal and ventricular remodeling.
Nature, 415 (2002), pp. 240-243
[31.]
D. Kumar, L.A. Kirhenbaum, I. Danelisen, P.K. Signal.
Apoptosis in adriamicin cardiomyopathy and its modulation by probucol.
Antiox Redox Signal, 3 (2001), pp. 135-145
[32.]
H. Jänkälä, C.J. Eriksson, K.K. Eklund, M. Härkönen, T. Mäki.
Combined calcium carbimide and ethanol treatment induces high blood acetaldehyde levels, myocardial apoptosis and altered expression of apoptosis-regulating genes in rat.
Alcohol Alcoholism, 37 (2002), pp. 222-228
[33.]
R. Aikawa, K.Y. Nitta, S. Kudoh, H. Takano, T. Nagai, Y. Yazaki, et al.
Reactive oxygen species induce cardiomyocyte apoptosis partly through TNF-aplha.
Cytokine, 18 (2002), pp. 179-183
[34.]
J. Narula, N. Haider, R. Virmani.
Apoptosis in myocytes in end-stage heart failure.
N Engl J Med, 335 (1996), pp. 1182-1189
[35.]
R.S. Williams.
Apoptosis and heart failure.
N Engl J Med, 96 (1999), pp. 1580-1585
[36.]
G. Olivetti, R. Abbi, F. Quani.
Apoptosis in the failing human heart.
N Engl J Med, 336 (1997), pp. 1131-1141
[37.]
B.K. Hong, H.M. Kwon, K.H. Byun, D. Kim, E.Y. Choi, T.S. Kang, et al.
Apoptosis in dilated cardiomyopathy.
Korean J Intern Med, 15 (2000), pp. 56-64
[38.]
J. Charper, S. Lorenz-Meyer, K. Suzuki.
The role of apoptosis in dilated cardiomyopathy.
Herz, 24 (1999), pp. 219-224
[39.]
J.P. Schmitt, J. Schroder, H. Schunkert, D.E. Birnbaum, H. Aebert.
Role of apoptosis in myocardial stunning after hearsurgery.
Ann Thorac Surg, 73 (2002), pp. 1229-1235
[40.]
M. Valente, F. Calabrese, G. Thiene, A. Angelini, C. Basso, A. Nava, et al.
In vivo evidence of apoptosis in arrhitmogenic right ventricular cardiomyopathy.
Am J Pathol, 152 (1998), pp. 479-484
[41.]
Z. Mallat, P. Fornes, R. Costagliola, B. Expósito, J. Belmin, D. Lecompte, et al.
Age and gender effects on cardiomyocyte apoptosis in the normal human heart.
J Gerontol Biol Med Sci, 56 (2001), pp. 19-23
[42.]
A. Newby, A.B. Zalsman.
Molecular mechanisms in intimal hyperplasia.
J Pathol, 190 (2000), pp. 300-309
[43.]
T. Polte, S. Oberle, H. Schröder.
Nitric oxide protects endothelial cells from tumor necrosis factor-c-induced cytotoxicity: possible involvement of cyclic GMP.
FEBS Lett, 409 (1997), pp. 46-48
[44.]
P. Hamet, N. Thorin-Trescases, P. Moureau, B.S. Tea, D. deBlois, V. Kren, et al.
Excess growth and apoptosis. Is hypertension a case of accelerated aging of cardiovascular cells?.
Hypertension, 37 (2001), pp. 760-766
[45.]
A. González, B. López, S. Ravassa, R. Querejeta, M. Larman, J. Díez, M.A. Fortuño.
Stimulation of cardiac apoptosis in essential hypertension. Potential role of angiotensin II.
Hypertension, 39 (2002), pp. 75-80
[46.]
J. Díez, A. Panizo, M. Hernández, J. Pardo.
Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats?.
Hypertension, 29 (1997), pp. 776-780
[47.]
M.A. Fortuño, G. Zalba, S. Ravassa.
P-53 mediated upregulation of BAX gene transcription is not involved in bax-alpha protein expression in the left ventricle of spontaneously hyperensive rats.
Hypertension, 33 (1999), pp. 1348-1352
[48.]
H.D. Integan, E.L. Schiffrin.
Vascular remodeling in hypertension. Roles of apoptosis, inflammation and fibrosis.
Hypertension, 388 (2001), pp. 581-587
[49.]
A.M. Scharifi, E.L. Schiffrin.
Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist.
Am J Hypertens, 11 (1998), pp. 1108-1116
[50.]
Y.J. Geng, P. Libby.
Evidence for apoptosis in advanced human atheroma.
Am J Pathol, 147 (1995), pp. 251-266
[51.]
S. Björkerud, B. Björkerud.
Apoptosis is abundant in human atherosclerotic lesions, specially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability.
Am J Pathol, 149 (1996), pp. 367-380
[52.]
M.M. Kockx, M.W.M. Knaapen.
The role of apoptosis in vascular diseases.
J Pathol, 190 (2000), pp. 267-280
[53.]
K. Walsh, R.C. Smith, H.S. Kim.
Vascular cell apoptosis in remodeling, restenosis and plaque rupture.
Circ Res, 87 (2002), pp. 184-188
[54.]
W.R. MacLellan, M.D. Schneider.
Death by design. Programed cell death in cardiovascular biology and disease.
Circ Res, 81 (1997), pp. 137-144
[55.]
M. Crisby, B. Kallin, J. Thyberg, B. Zhivotovsky, S. Orrenius, V. Kostulas, et al.
Cell death in human atherosclerotic plaques involves both oncosis and apoptosis.
Atherosclerosis, 130 (1997), pp. 17-27
[56.]
S. Dimeler, V. Rippmann, U. Weiland, J. Haendeler, A. Zeiher.
Angiotensin II induces apoptosis in human endotelial cells. Protective effect of nitric oxide.
Circ Res, 81 (1996), pp. 970-976
[57.]
K.M. Cromheeke, M.M. Kockx, G.R.Y. De Meyer.
Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques.
Cardiovasc Res, 9 (1999), pp. 744-754
[58.]
D.M. Hockenbery, Z.N. Oltvai, X.M. Yin, C.l. Milliman, S.J. Korsemeyer.
Bcl-2 functions in an antioxidant pathway to prevent apoptosis.
Cell, 75 (1993), pp. 241-251
[59.]
R.L. Hajjar, F. del Monte, T. Matsui.
Rosenzweig. Prospects for gene herapy for heart failure.
Circ Res, 86 (2000), pp. 616-621
[60.]
M.J. Pollman, J.L. Hall, M.J. Mann, L. Zhang, G.H. Gibbons.
Inhibition of neointimal cell BCL-x expression induces apoptosis and regression of vascular disease.
Nature Med, 4 (1998), pp. 222-227
[61.]
N.M. Rajamannan, G. Sangiorgi, M. Springett, K. Arnold, T. Mohacsi, L.G. Spagnoli, et al.
Experimental hypercholesterolemia induces apoptosis in the aortic valve.
J Heart Valve Dis, 10 (2001), pp. 371-374
[62.]
M. Araki, K. Hassegawa, E. Iwai-Kanai, M. Fujita, T. Sawamura, T. Kakita, et al.
Endothelin-1 as a protective factor against beta-adrenergic agonist-induced apoptosis inc ardiac myocytes.
J Am Coll Cardiol, 36 (2000), pp. 1411-1418
[63.]
R. Aikawa, M. Nawano, Y. Gu, H. Atagiri, T. Asano, W. Zhu, et al.
Insulin prevents cardiomyocyte from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt.
Circulation, 102 (2000), pp. 2873-2879
[64.]
R. Nevière, H. Fauvel, C. Chopin, P. Formstecher, P. Marchetti.
Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis.
Am J Respir Crit Care Med, 163 (2001), pp. 218-225
[66.]
N. Sudoh, K. Toba, M. Akishita, J. Ako, M. Hashimoto, K. Iilima, et al.
Estrogens prevents oxidative stress-induced endothelial cell apoptosis in rats.
Circulation, 103 (2001), pp. 724-729
[67.]
I.S. Choi, B.S. Kim, K.S. Cho, J.C. Park, M.H. Jang, M.C. Shin, et al.
Amiodarone induces apoptosis in L-132 human lung epitelial cell line.
Toxicol Lett, 132 (2002), pp. 47-55
[68.]
T. Kakita, K. Hasegawa, E. Iwai-Kanai, S. Adachi, T. Morimoto, H. Wasa, et al.
Calcineurin pathway is required for endothelin-1 mediated protection against oxidant stress-induced apoptosis in cardiac myocytes.
Circ Res, 88 (2001), pp. 1220-1222
[69.]
N.V. Guevara, L. Chan.
Apoptosis in atherosclerosis; pathological and pharmacological implications.
Pharmacol Res, 44 (2001), pp. 59-71
[70.]
L.W. Miller, D.J. Granville, J. Narula, B.M. McManus.
Apoptosis in cardiac transplant rejection.
Cardiol Clin, 19 (2001), pp. 141-154
[71.]
J.T. Bowles.
The evolution of aging: a new approach to an old protein biology.
Med Hyac Theses (Engl), 31 (1998), pp. 179-221
[72.]
J. Fernández-Solà, J.M. Nicolas-Arfelis.
Apoptosis e implicaciones clínicas.
Med Interna, 17 (1999), pp. 425-468
Copyright © 2003. Sociedad Española de Arteriosclerosis y Elsevier España, S.L.